Diabetes, a state of improperly regulated homeostasis of carbohydrate and lipid metabolism is one of the major killers in recent times. Most prevalent form of diabetes is non insulin dependent diabetes mellitus (NIDDM/type II). Rapid hydrolysis of starch mediated by pancreatic α-amylase and α-glucosidases followed by glucose uptake at intestine results in sudden rise in blood glucose levels, causing hyperglycemia in type II diabetes patients. α-glucosidase inhibitors act as competitive inhibitors of enzymes needed to digest carbohydrates: specifically alpha-glucosidase enzymes in the brush border of the small intestines. Inhibition of these enzyme systems reduces the rate of digestion of carbohydrates. Less glucose is absorbed because the carbohydrates are not broken down into glucose molecules. Natural α-glucosidase inhibitors such as Acarbose and Miglitol used for management of diabetes widely, but they are associated with side effects, in this review search for more natural alpha-glucosidase inhibitors are discussed which are safer as compared to insulin and other oral hypoglycaemic drugs.
REVIEW ON ROLE OF NATURAL ΑLPHA-GLUCOSIDASE INHIBITORS FOR MANAGEMENT OF DIABETES MELLITUS
K. J. Naquvi,J. Ahamad,S. Mir,Mohd. Ali,M. Shuaib
Published 2011 in International journal of biomedical research
ABSTRACT
PUBLICATION RECORD
- Publication year
2011
- Venue
International journal of biomedical research
- Publication date
2011-07-01
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-15 of 15 references · Page 1 of 1
CITED BY
Showing 1-57 of 57 citing papers · Page 1 of 1